VKTX jumps after VK2735 shows weight-loss maintenance on reduced dosing
Viking Therapeutics said VK2735 helped patients maintain most weight loss when moved from once-weekly dosing to every-other-week dosing.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.